Press releases

ENDOSURE appoints EndoDiagnosis, Inc. Canadian Distributor to Revolutionize Endometriosis Detection in Canada with 30-Minute Non-Invasive ENDOSURE TEST

ENDOSURE appoints EndoDiagnosis, Inc. Canadian Distributor to Revolutionize Endometriosis Detection in Canada with 30-Minute Non-Invasive ENDOSURE TEST

EndoDiagnosis is changing the landscape of women’s healthcare with its new role as the sole distributor in Canada for the ENDOSURE Tier 1 diagnostic test for endometriosis. This new diagnostic tool marks a significant shift in how endometriosis is detected and managed, cutting down the average diagnosis time from over eight years to just 30 minutes.

ENDOSURE Tier 1 Endometriosis Testing Now Available in North America for First Time, Through Primary Care Clinic Marda Loop Wellness

ENDOSURE Tier 1 Endometriosis Testing Now Available in North America for First Time, Through Primary Care Clinic Marda Loop Wellness

A North America first, primary care clinic Marda Loop Wellness is now offering ENDOSURE. This innovative, non-invasive diagnostic tool delivers results in 30 minutes with over 99% accuracy, addressing a critical gap in women’s healthcare where traditional diagnosis typically takes 8.6 years globally. The integration of ENDOSURE testing at Marda Loop Wellness aligns with the clinic’s unique approach to women’s healthcare. Patients can schedule ENDOSURE testing appointments beginning June 16, 2025.

Hope for Rapid, Non-Invasive Endometriosis Diagnosis

Hope for Rapid, Non-Invasive Endometriosis Diagnosis

A breakthrough in women’s health: The ENDOSURE test delivers 99.87% accurate, non-invasive results for endometriosis in under an hour, potentially transforming care and cutting years off diagnosis time. Despite its Health Canada approval, access remains limited. Clinicians and advocates urge wider adoption to reduce delays, improve outcomes, and support early intervention for the 1 in 10 women affected. EndoDiagnosis aims to bring access to testing to patients and clinics across Canada.